Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go:
Expired
investment:
£192,280
Core Collective is a luxury boutique fitness destination with a pay as you go model and an immersive and dynamic atmosphere. They provide all the benefits of a personal training session in a small class for a fraction of the cost and offer 7 different classes available for all levels of fitness.
days to go:
Expired
investment:
£2,056,412
A crisps company with the mission of making tasty and healthy snacks. Emily Crisps are vegan, gluten-free, halal and kosher certified, as well as being 1 of a 5 per day. Their products are sold in major grocery stores such as Sainsbury's and Tesco, which are responsible for 50% of the company's revenue. Emily Crisps are well-established in the UK and are now seeking funds to expand to the US, with a dedicated marketing campaign and sales team.
days to go:
Expired
investment:
£1,048,030
Priding themselves with their Aussie-Japanese sushi handrolls, Inigo have introduced the delicacy to London and are now ready to expand. The company has partnered with a leading smokehouse, H. Forman & Son's who provide the kitchen, produce and expertise. Inigo currently have operate from a kiosk in the city centre, with more planned. They offer B2B services and supply corporate businesses including Visa HQ, Amazon HQ and UBS.
days to go:
Expired
investment:
£179,840
Agua de Madre is craft-brewed water kefir aimed at the evergrowing no- and low- alcohol UK market. It aims to be an ethical brand that makes a delicious drink with live bacteria up to 250 billion live cultures per 100ml. The naturally low-alcohol fizzy water kefir is sold in deli's, restaurants, bars, and other food stores in London. Agua de Madre has also attracted media interest from major publications including Metro, Vogue, and Wallpaper. Furthermore, the company is planning to maximise its production potential, hire a specialist sales agency Windfall, expand to sell further in southwest London, and ramp up marketing with its PR Agency, Visible.
days to go:
Expired
investment:
£250,990
Signature Brew strives to craft beer that enhances the musical experience. Since 2011, their mission has been to create more collaborative beers with bands and musicians than any other brand globally. Through the success of their flagship beers, Studio Lager and Roadie All-Night IPA, they aim to spread their vision of uniting people through exceptional beer, music, and memorable experiences on a national and international scale.
Continuing their original objective of improving the beer scene at beloved venues and festivals, Signature Brew remains committed to this ethos. Their direct-to-consumer customer base is expanding across the UK, driven by partnerships with artists and venues within their community. Operating from their cutting-edge brewery in East London, which includes an iconic live music venue, they consistently produce award-winning beer while fervently supporting grassroots music.
days to go:
Expired
investment:
£872,392
